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A Functional Enhancer Suppresses Silencing
of a Transgene and Prevents Its Localization
Close to Centromeric Heterochromatin
number of studies on these ªposition effects.º For exam-
ple, gene silencing can be mediated by chromosomal
rearrangements that place a gene in or close to hetero-
chromatin. These position effects lead to a clonally in-
herited variegated phenotype in which the gene is ex-
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pressed at normal levels in some cells and is silenced²Department of Radiation Oncology
in other cells. Related phenomena, such as telomericUniversity of Washington School of Medicine
and mating type silencing in yeast or chromosome XSeattle, Washington 98195
inactivation, have also been reported (reviewed in Heni-
koff, 1992).
Recent studies have revealed that gene silencing bySummary
heterochromatin can also involve the movement of ge-
netic loci within the nucleus to a repressive nuclearTo explore the mechanism by which enhancers main-
compartment close to heterochromatin (reviewed intain gene expression, we have assessed the ability
Cockell and Gasser, 1999). For example, Sir-dependentof an enhancer and derivative mutants to influence
telomeric and mating type locus silencing in yeast issilencing and nuclear location of a transgene. Using
associated with compartmentalization of the silencedsite-specific recombination to place different con-
gene in the nuclear periphery, where Sir proteins arestructs at the same integration sites, we find that
concentrated (Aparicio et al., 1991; Chien et al., 1993;disruption of core enhancer motifs impairs the en-
Gotta and Gasser, 1996; Maillet et al., 1996). In higherhancer's ability to suppress silencing. FISH analysis
eukaryotes, silencing can involve the movement ofreveals that active transgenes linked to a functional
genes close to centromeric heterochromatin. In Dro-enhancer localize away from centromeres. However,
sophila, the insertion of a block of heterochromatin intoenhancer mutations that result in increased rates
one allele of the euchromatic brown gene results in theof transgene silencing fail to localize the transgene
association of both alleles with centromeric heterochro-away from centromeric heterochromatin, even when
matin, leading to transcriptional inactivation of the wild-the transgene is in an active state. These mutations
type allele (Csink and Henikoff, 1996; Dernburg et al.,thus dissociate transcriptional activity and subnuclear
1996). More recently, it has been demonstrated thatlocation. Together, our results suggest that the func-
gene silencing in mammalian cells may be mediated bytional enhancer antagonizes gene silencing by pre-
the factor Ikaros, which associates with silent genesventing localization of a gene near centromeric hetero-
and centromeres in lymphocytes (Brown et al., 1997,chromatin.
1999). In all of these cases, there is an observed associa-
tion between silent genes and heterochromatin, but it
Introduction is not clear whether the association with heterochroma-
tin is the cause or the consequence of silencing.
Numerous studies have demonstrated that transcrip- Once established, the silent state is stably inherited,
tion is controlled by the interaction of positive and but it can be antagonized by transcriptional activators.
negative regulatory factors with specific DNA elements For example, in yeast, telomeric silencing of URA3 is
flanking a gene. However, the eukaryotic genome is suppressed by binding of the transcriptional activator
organized in a complex and heterogeneous structure PPR1 to its promoter (Aparicio and Gottschling, 1994).
termed chromatin, which is not homogeneous for tran- In Drosophila, mutations in the GAGA factor, a transcrip-
scriptional activity. For example, telomeres and cen- tional activator involved in chromatin decondensation,
tromeres are associated with more condensed, higher- are dominant enhancers of position±effect variegation
order chromatin structure, termed heterochromatin, (PEV) (Farkas et al., 1994). Furthermore, silencing of
which is thought to repress transcription (reviewed in transgenes in cultured mammalian cells and in mice is
Wolffe and Pruss, 1996; Gregory and Horz, 1998; Kado- suppressed by inclusion of transcriptional enhancers in
naga, 1998; Wakimoto, 1998). However, the general role the transgene (Walters et al., 1995, 1996; Sutherland et
of chromatinÐmore precisely, the interplay of transcrip- al., 1997). Moreover, deletion of the enhancer from an
tional regulators and repressive chromatin in regulating integrated construct led to a rapid loss of expression of
transcriptionÐis still poorly understood. the reporter gene (Walters et al., 1996). In combination,
Alteration of the position of a gene relative to hetero- these results suggest that transcriptional activators
chromatin can affect its expression status; effects of bound to enhancer elements act to maintain genes in
an active state by disrupting or preventing the formationchromatin on gene expression are suggested by a large
of repressive chromatin.
To further explore the mechanisms by which en-
³ To whom correspondence should be addressed (e-mail: d.martin@ hancers maintain gene expression in repressive chro-
victorchang.unsw.edu.au [D. I. K. M.], markg@fhcrc.org [M. G.]).
matin environments, we have assessed the ability of an§ Present address: Division of Hematology/Oncology, Children's
enhancer and derivative mutants to suppress silencingHospital, Oakland, California 94609.
of a transgene, using a method that controls for position‖ Present address: The Victor Chang Cardiac Research Institute, 384
Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia. effects. Our results show that the ability of an enhancer
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Figure 1. DNA Constructs Used to Evaluate
the Role of Transcription Factors in Main-
taining Expression
59HS2 consists of a 1 kb SmaI/BglII fragment
(S/Bg), and the core enhancer is a 380 bp
XbaI/HindIII fragment (X/H). The major bind-
ing sites in the core enhancer are boxed. Part
of the core enhancer sequence is shown, and
the bases modified by oligonucleotide-directed
mutagenesis are indicated. The two single
base mutations in the tandem NF-E2-binding
site (mNF-E2) have been shown to abolish
NF-E2 binding to this site. The GATA and the
CACC sites have been scrambled. m3sites
is a combination of mutations in the GATA,
CACC, and GT boxes, leaving the NF-E2 site
intact. m4sites disrupts all major binding sites
in the core enhancer. The (HS2core)g con-
struct links the HindIII/XbaI fragment to the
g-globin promoter, preserving the spacing
between the Xba site and the 39end of the
promoter found in the constructs with the
full-length enhancer. 59HS2 or the different
mutated versions of it were linked to the
g-globin promoter and inserted in the single
LoxP or pL1L2 vectors, for targeted reinte-
gration by Cre.
to suppress silencing relies on the integrity of core en- Mutation of the 59HS2 Enhancer
In earlier experiments, we found that the erythroid en-hancer motifs. At genomic integration sites where stable
hancer 59HS2 would suppress or retard silencing of aexpression does not require the presence of an en-
reporter construct randomly integrated into the genomehancer, transgenes localize away from centromeric het-
of cultured erythroid cells (Walters et al., 1996). We hy-erochromatin in interphase nuclei, regardless of trans-
pothesized that binding of transcriptional activators togene activity or integrity of the enhancer. In contrast, at
the enhancer is responsible for the observed ability ofsites where stable expression requires an intact en-
59HS2 to suppress transgene silencing, and as a test ofhancer, active transgenes localize away from centro-
this hypothesis, we disrupted the core enhancer-bindingmeric heterochromatin when linked to a functional en-
sites in 59HS2. 59HS2 is a region of the b-globin LCRhancer. Enhancer mutations that impair the ability of
that exhibits classical enhancer activity in transientthe enhancer to suppress silencing also result in the
assays and increases the probability of gene expressiontransgene remaining in close proximity to centromeric
in colony assays and transgenic mice (for review, Hardi-heterochromatin even before the transgene is silenced.
son et al., 1997). The core enhancer, a 300 bp XbaI/This mutational analysis demonstrates that the same
HindIII fragment, has been shown to be sufficient forenhancer motifs are required for both suppression of
the enhancer activity of 59HS2 and the formation of thetransgene silencing and localization of the transgene
hypersensitive site (Caterina et al., 1991, 1994; Liu etaway from centromeric heterochromatin. These muta-
al., 1992). A group of motifs at the DNase I hypersensitivetions also dissociate transcriptional activity per se from
core of 59HS2 are binding sites for ubiquitous and hema-subnuclear location. In combination, these results sug-
topoietic-specific transcription factors. We chose to dis-gest that transcriptional enhancers may maintain gene
rupt these motifs because they have been previouslyexpression by preventing localization of a gene near
shown to be necessary for enhancer activity of 59HS2centromeric heterochromatin and/or by recruiting a
in other assays and have been shown by in vivo foot-gene to a nuclear compartment in which transcription
printing assays to be occupied by transcription factorsis favored and stably heritable.
in the K562 erythroid cell line (Ikuta and Kan, 1991;
Reddy and Shen, 1991). The structure of the mutants is
Results shown in Figure 1. These motifs can be bound by multi-
ple factors, and there is some uncertainty regarding
Experimental Strategy which factors occupy these sites in erythroid cells (re-
To study the effects of transcriptional activators on gene viewed in Orkin, 1995). GATA-1 is the major factor bind-
silencing in cultured cells, we have made use of the ing to GATA motifs in erythroid cells. NF-E2 is a com-
bifunctional reporter b-geo, a fusion of neoR and LacZ pound heterodimer, and the precise composition of the
activities. Clones carrying integrated copies of b-geo species binding 59HS2 in erythroid cells has not been
constructs can be selected and expanded in G418, and established. CACC motifs in 59HS2 may be occupied by
as long as G418 selection is maintained, they are uni- EKLF or one of its homologs but can also be bound by
formly b-gal positive. When G418 selection is removed, SP1. We introduced two single base mutations into the
silencing of b-geo over time can be observed by serial tandem NF-E2-binding site; these mutations were pre-
viously shown to disrupt NF-E2 (but not AP-1) bindingflow cytometric assays of b-gal.
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to the site (Romeo et al., 1990; Andrews et al., 1993)
and severely impair enhancer activity. The other motifs
have been scrambled. The m3sites mutant has the GATA
and CACC sites disrupted, leaving the NF-E2 motif in-
tact. The m4sites mutant disrupts all major binding sites
in the core enhancer. The (HS2core)g construct links the
HindIII/XbaI fragment to the g-globin promoter, retaining
the spacing between the HindIII site and the start of the
promoter found in the constructs with the full-length
enhancer.
In experiments with this set of enhancer mutants, our
goal was to establish (1) whether disruption of sites
known to be critical for the classical enhancer effect of
59HS2 also abolished its ability to suppress silencing,
and (2) whether disruption of the enhancer affected the
chromatin structure or subnuclear localization of a
transgene.
Targeted Integration in the Genome
of Cultured Cells
In order to compare the ability of the 59HS2 enhancer
and its derivative mutants to suppress silencing of
transgene activity, it is necessary to integrate a series
of test constructs into the same genomic site, because
each site has a characteristic ability to silence an inte-
grated transgene, and this ability varies widely. For this
reason, we employed two general methods that use
the Lox/Cre system of site-specific recombination to
exchange components of single-copy transgenes at a Figure 2. Site-Specific Integration of b-Geo Constructs by Expres-
given genomic site in cultured cells; these methods have sion Trap Strategy or RMCE
been described in detail elsewhere (Bouhassira et al., (A) Expression trap strategy. A parental b-geo construct, in which
1997; Walters et al., 1999), and the strategies are sum- promoter and enhancer sequences were flanked by LoxP elements,
was integrated into the genome of K562 erythroleukemia cells. Tran-marized in Figure 2.
sient expression of Cre recombinase deletes promoter and en-The first method (Figure 2A) involves an intermediate
hancer, leaving a single LoxP element upstream of b-geo. This LoxPstep in which the promoter has been deleted, leaving a
site can be then used as a trap for integration of the enhancer/LoxP site, which can be used as a trap for integration of
promoter cassettes described in Figure 1. Reintegration of a pro-
the cassettes described in Figure 1. The second method moter will result in expression of b-geo and so can be selected for
(Figure 2B) relies on the poor efficiency of recombination with G418.
(B) RMCE. A CMV/HyTK construct flanked by two incompatible LoxPbetween LoxP elements that differ in their spacer regions
elements is integrated into the K562 genome. A second plasmid, inand has been termed recombinase-mediated cassette ex-
which b-geo and the control elements to be tested are also flankedchange (RMCE). In contrast to the first method described
by the incompatible LoxP elements, is then cotransfected with aabove, RMCE does not involve an intermediate step in
Cre expression plasmid. Recombination between compatible LoxP
which the marker at the integration site is silent. elements exchanges the b-geo cassettes and CMV/HyTK cassette;
We used both methods to place mutant enhancers at this event can be selected for with G418 and Gancyclovir and con-
firmed by Southern blot.integration sites derived by random integration. Con-
structs were placed in sites 1 and 6.2 using the single
LoxP trap strategy and in site C30 by RMCE (Walters
et al., 1999). Sites 6.2 and C30 were chosen because zero, when G418 selection is removed and all cells are
the reporter construct at this site is silenced over a expressing. Silencing was assayed with FACS-Gal, a
period of weeks, thus permitting us to assess the effects highly sensitive flow cytometric method that distin-
of altering components of the transgene. In contrast to guishes cells containing b-gal activity from those that
sites 6.2 and C30, reporter silencing at site 1 is a rare do not (Fiering at al., 1991).
event, even in the absence of an enhancer. Thus, site Consistent with our previous findings, inclusion of an
1 provides an opportunity to compare the mechanism enhancer in the transgene has a dramatic effect on the
of silencing at sites in which transgene expression is time course of b-geo silencing at two of the three ran-
relatively unstable (sites 6.2 and C30) with silencing at dom integration sites (Figure 3). In site 6.2, the transgene
an integration site that is very permissive for expression. containing the wild-type 59HS2 remains active in more
than 60% of the cells 20 weeks after removal of selec-
tion, whereas a transgene lacking 59HS2 becomes silentSuppression of Silencing by 59HS2 Is Dependent
on the Integrity of Core Enhancer Motifs in 90% of the cells within the same period. Similar results
were obtained at site C30 (Figure 3 and Walters et al.,The wild-type enhancer and its derivative mutants were
integrated by Cre recombinase at the three sites dis- 1999). Mutation of either the GATA sites (Figure 3) or
the CACC sites (data not shown) alone has no effect oncussed above, in K562 erythroleukemia cells. The time
course of b-geo silencing was followed from a time point the ability of 59HS2 to suppress silencing. In contrast,
Cell
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Figure 3. Contribution of Core Enhancer Motifs to Suppression of Transgene Silencing
FACS-Gal assays of K562 cells carrying wild-type and mutant 59HS2 enhancer constructs at three integration sites. At sites 6.2 and C30, the
intact 59HS2 enhancer suppresses silencing of the b-geo reporter; mutations in the core enhancer abolish this effect. At site 1, little silencing
occurs even in the absence of the enhancer. Cells were removed from G418 selection at time point zero, at which all cells are expressing.
Proportion of expressing and silent viable cells was measured with FACS-Gal. The silencing of the different constructs over time is represented
as the percentage of expressing cells at a given time (y axis) versus the time in weeks during which cells were expanded in the absence of
G418 (x axis). Each point represents the mean of at least two clones per construct and two or three independent experiments. Error bars
represent SD.
a mutation that disrupts binding of the erythroid factor We assessed methylation by digestion of genomic
DNA with HpaII and MspI, which are sensitive and insen-NF-E2 results in a silencing of expression at a rate equiv-
alent to that seen in the absence of 59HS2. When the NF- sitive, respectively, to CpG methylation. This method
reveals that the b-geo transgene is heavily methylatedE2 site was left intact but the neighboring GATA-1- and
CACC-binding motifs were disrupted (m3sites), the activity when in an inactive state and relatively unmethylated
of the enhancer was also abolished. Finally, deletion of when active (Figure 4). The methylation status of the
all known binding sites in the core enhancer (m4sites) transgene is independent of the presence of an intact
also abolishes 59HS2 function, whereas deletion of the enhancer: the transgene carrying a mutant enhancer
sequences flanking the core (HS2core-g) does not alter
the ability of the 59HS2 enhancer to suppress silencing
of the transgene. Moreover, b-geo expression level in
the active state is the same regardless of the integrity
of the 59HS2 enhancer (data not shown), consistent with
our previous findings (Walters et al., 1996). These results
support the hypothesis that suppression of transgene
silencing by 59HS2 depends on binding of its previously
characterized core motifs by transcriptional activators.
None of the constructs integrated at site 1 showed
any significant silencing of b-geo after 6 months without
selection, regardless of the presence or absence of an
enhancer. These results suggest that site 1 resides in
a permissive chromatin environment, in which stable
expression does not require strong activating elements
in the transgene (see Discussion).
Figure 4. CpG Methylation Analysis of the Transgene
Chromatin Structure of the Transgene Correlates
MspI/HpaII digests of genomic DNA from expressing and silent cells
with Transcription State Rather Than (separated by FACS-Gal), Southern blotted and probed with the
Integrity of the Enhancer transgene. Both enzymes recognize the sequence CCGG; when the
We compared the structure of the transgene in its active internal C is methylated, MspI but not HpaII cleaves the sequence
(methylation of the external C inhibits both enzymes). An identicaland silent states by assessing CpG methylation, DNase
digestion pattern with the two enzymes indicates a lack of CpG methyl-I sensitivity, and restriction enzyme accessibility. After
ation, whereas the presence of large HpaII fragments indicates methyl-maintenance of cell populations for several weeks with-
ation. This analysis shows that the transgene is heavily methylated inout G418 selection, the mixed populations of expressing
silent cells (2) and has little CpG methylation in expressing cells (1).
and nonexpressing cells (as seen in Figure 3) were sub- There is a small amount of CpG methylation in the expressing
jected to FACS-Gal and sorted to produce groups in transgene at site C30. Mutation of the NF-E2 site in the core 59HS2
does not affect the methylation pattern of the active transgene.which the transgene was either active or silent.
Enhancer-Mediated Relocalization of Transgenes
263
has the same degree of methylation as one with the 50 nuclei per construct were collected; distances be-
tween the transgene signal and the closest centromerewild-type enhancer, as long as both are in the same
transcriptional state. were measured and divided by the cell radius. We found
that, at sites 6.2 and C30, the median distance is signifi-Chromatin structure analyses reveal that the silenced
transgene [HS2g(2)] is devoid of DNase I hypersensitive cantly smaller in silent cells than it is in expressing cells
[Figure 7, compare HS2g(2) with HS2g(1)]. This con-sites (HS) and inaccessible to restriction enzymes, indi-
cating that it is in a ªclosedº chromatin configuration. firms that silencing of the transgene at unstable sites is
associated with repositioning of the transgene intoIn contrast, all transcriptionally active transgenes we
examined contain a DNase I hypersensitive site at the closer proximity to centromeric DNA.
In contrast to the repositioning of the transgene asso-promoter (Figure 5B) and are accessible to restriction
enzymes (Figure 5C). The HS at the core region of 59HS2 ciated with silencing at sites 6.2 and C30, at site 1 the
distance between the transgene and centromeres doesis present only in transcriptionally active transgenes
containing a functional enhancer (as reflected in its abil- not vary, regardless of the activity of the transcription
unit (Figures 6 and 7). The deleted intermediate at siteity to suppress silencing). For example, HS2 is present
in active constructs containing a wild-type enhancer 1 (which lacks a promoter) is no closer to the centromeric
probe than are active transgenes. These findings sug-[HS2g(1)]; mutation in the GATA site does not prevent
formation of this HS (mGATA), but disruption of the NF- gest that the endogenous locus at site 1 localizes consti-
tutively away from repressive centromeric heterochro-E2 site (mNF-E2) or disruption of all core enhancer motifs
(m4sites, data not shown) results in loss of the HS. In matin. They also suggest that silencing does not require
an association with centromeric heterochromatin.contrast to DNase I hypersensitivity, accessibility of the
enhancer to restriction enzyme digestion does not
change when the core NF-E2 motif is mutated. We ana- At Unstable Expression Sites, a Functional Enhancer
lyzed digestion of a BspHI site in the NF-E2 motif; the Is Required for Transgene Positioning away
site is inaccessible in a silent transgene, but accessi- from Centromeric Heterochromatin
ble when the transgene is active, regardless of whether The FISH analysis (Figures 6 and 7) indicates that at
the NF-E2 motif (and thus enhancer activity) is intact sites in which transgene expression is unstable (sites 6.2
(Figure 5C). and C30), transgenes containing a wild-type enhancer
The methylation and DNase I analyses show that the localize away from the centromeric probe when active
process of silencing we observe is associated with a [Parent and HS2g(1)]. In addition, at these unstable
stable alteration of the structure of the transgene. They sites, the silent state is associated with closer proximity
also reveal that active transgenes have the same struc- to centromeric DNA. Consistent with these results, dele-
ture regardless of the binding of transcription factors to tion of the enhancer and promoter from the parent con-
the core enhancer. These results suggest that enhancer- struct integrated in site 6.2 results in close proximity
bound activators increase the stability of expression of the silent transgene to centromeric heterochromatin
and the stability of the active chromatin structure, but (Figure 7, Deleted). At site 6.2, integration of a construct
do not affect the structural phenotype of the active chro- carrying a wild-type enhancer into this silent promoter
matin state. Thus, we sought evidence of some other trap results in transgene relocalization away from cen-
structural correlate of enhancer activity. tromeres [Figure 7, compare Deleted construct and
HS2g(1)]. These results suggest that the native locus
at site 6.2 may reside close to centromeres in interphaseTransgenes Can Be Silenced at a Distance from
Centromeric Heterochromatin during Interphase nuclei, and that insertion of a wild-type enhancer and/
or an active transcription unit leads to the relocalizationSince several reports have described a correlation be-
tween gene silencing and proximity to heterochromatin, of this locus away from heterochromatin.
Based on their behavior in the transgene silencingwe asked whether silencing of the b-geo transgene in
K562 cells involves a change in its nuclear localization. assay described above (Figure 3), the 59HS2 enhancer
mutants inserted at unstable sites 6.2 and C30 fall intoWe performed dual-color fluorescent in situ hybridiza-
tion (FISH) using a human a satellite probe detecting all two classes: (1) those that silence at the same rate as
the wild-type enhancer (e.g., mGATA), and (2) those thathuman centromeres (red) and a plasmid probe covering
the entire transgene (green). Analysis of metaphase silence as rapidly as in the absence of enhancer (e.g.,
mNF-E2 and m4sites). Thus, to determine whether relo-chromosomes demonstrates that the transgene at site
1, 6.2, or C30 is integrated on the long arm of three cation of the transgene away from centromeric hetero-
chromatin is associated with the presence of the intactdifferent chromosomes, in noncentromeric positions
(Figure 6A). enhancer, or with transcription per se, we examined
the effects of each class of enhancer mutation on theWe examined homogeneous populations of silent and
expressing cells sorted by FACS and compared the nuclear location of active transgenes during interphase.
Integration in the promoter trap (site 6.2) of the activedistance between the transgene and the centromeric
probe in reconstructed three-dimensional images of in- mGATA construct, which silences at the same rate as
the wild-type enhancer, results in the relocation of theterphase nuclei (see Experimental Procedures). Exam-
ples of this FISH analysis are shown in Figure 6B. In cells transgene away from centromeric DNA. In clear con-
trast, when reintegrated into the same promoter trap,harboring wild-type transgenes at unstable expression
sites 6.2 and C30, the transgene appears closer to a constructs carrying enhancers in which all known core
binding sites or the tandem NF-E2 site alone are dis-centromere in silent cells than it does in expressing cells.
To confirm this observation, images from approximately rupted fail to relocate away from the centromeric probe,
Cell
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Figure 5. DNase I and RE Accessibility Anal-
ysis of the Transgene
(A) Map of the transgene showing DNase I
hypersensitive and restriction enzymes sites.
The large and small arrows indicate the hy-
persensitive sites at the enhancer and the
promoter, respectively. BspHI cuts in the NF-
E2 site of 59HS2, and HindIII cuts at the 39
end of the g-globin promoter. EcoRV or PstI,
which cuts only once in the transgene, was
used to digest genomic DNA prepared from
nuclei. The 1 kb fragment for LacZ, used as
a probe, is indicated.
(B) Silencing is associated with loss of DNase
I hypersensitivity at the promoter and the en-
hancer; mutation of core enhancer motifs
abolishes the 59HS2 hypersensitive site. Nu-
clei from expressing (1) or nonexpressing (2)
sorted populations of cells carrying the
transgene at site 6.2 were digested with in-
creasing amounts of DNase I; genomic DNA
was then isolated, cut with EcoRV, Southern
blotted, and probed with the transgene. The
presence of a hypersensitive site at the pro-
moter generates a 1.2 kb fragment (arrow),
and at the enhancer a 1.8 kb fragment (arrow-
head). The silent transgene (2) is relatively
insensitive to DNase I treatment compared
to active transgenes (1) in which an HS is
detected at the promoter. The enhancer HS
is present in a construct containing a wild-
type 59HS2 and disappears with mutation of
the NF-E2 site, whereas disruption of the
GATA sites does not affect its formation.
(C) Restriction enzyme accessibility is lost
with silencing but does not require an intact
enhancer. Nuclei were digested with BspHI or HindIII; genomic DNA was extracted and digested with PstI. Cleavage at the BspHI site generates
a 3.8 kb fragment, and at the HindIII site a 3.5 kb fragment. The transgene is accessible to restriction enzyme digestion only in active
transgenes. Mutation of the NF-E2 site does not affect this accessibility.
even when the transgene is transcriptionally active [Fig- the transgene localizes away from centromeric hetero-
chromatin, regardless of its activity status or the pres-ure 7, compare Deleted construct and mNF-E2(1) or
ence of a functional enhancer. Thus, stability of the ac-m4sites(1)]. Similar results were obtained at site C30:
tive state, and not transcriptional activity per se, isthe active transgene carrying the wild-type 59HS2 local-
associated with distance from the centromeric compart-izes away from the heterochromatin probe, whereas the
ment. Moreover, at unstable sites, the intact enhancer,transgene carrying a mutant enhancer is found in close
and not transcription per se, is required for relocationproximity to centromeric heterochromatin even when
of the active transgene away from centromeric hetero-transcriptionally active. In contrast, at site 1, where
chromatin.transgene activity is stable over long periods of time
even in the absence of enhancer, the distance between
the transgene and centromeres does not vary, whether Discussion
it is active or silent. As expected, since the enhancer is
not required for stable expression at that integration The results reported here provide evidence that core
site, mutation of the NF-E2 motif does not affect the enhancer motifs are required to both suppress transgene
stability of transgene expression and does not result in silencing and relocate the gene away from centromeric
a change in the transgene's positioning relative to the heterochromatin during interphase. We previously re-
centromeric probe. ported that transgene silencing in erythroid cells is sup-
Thus, at sites where an enhancer is required for stable pressed by the activity of the 59HS2 enhancer (Walters
expression (sites 6.2 and C30), active constructs con- et al., 1996). Using a recombinase-mediated strategy to
taining an intact 59HS2 enhancer or an enhancer carrying assess multiple constructs at the same integration site,
a neutral mutation localize away from centromeric het- we now show that this suppression of silencing is asso-
erochromatin, whereas constructs carrying enhancer mu- ciated with relocalization of the transgene away from
tations that result in greater instability of the transgene centromeric heterochromatin. Moreover, we show that
remain associated with the centromeres while still ac- both suppression of silencing and relocalization require
tive. However, at a site where the stable expression of a functional enhancer.
Although transgene silencing at unstable expressionthe transgene is independent of an enhancer (site 1),
Enhancer-Mediated Relocalization of Transgenes
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Figure 6. Localization of the Transgene Rela-
tive to Centromeres
Fluorescence in situ hybridization (FISH) of
K562 cells with probes hybridizing to the
transgene (green) and the centromeres (red).
DAPI staining is shown as blue.
(A) Metaphase spreads from cells carrying
the HS2g construct integrated at sites 6.2,
C30, and 1. The transgene integration sites
are on the long arms of three different chro-
mosomes; none of the sites are proximal to
a centromere or a telomere.
(B) Images of interphase nuclei from cells car-
rying a construct containing an intact 59HS2
(HS2g) or 59HS2 in which the NF-E2 site was
disrupted (mNF-E2), integrated at sites 6.2,
C30, and 1. The pictures shown represent the
projection of 20 Z sections taken through the
nucleus. In sites 6.2 and C30, the green signal
for the transgene is found at a distance from
a red signal for centromeres in expressing
cells (1), whereas it is in close proximity in
silent cells (2) or when the NF-E2 site is dis-
rupted (mNF-E2). In site 1, the spatial position
of the transgene relative to centromeres is
similar for all three examples.
sites is associated with proximity with centromeric het- distance from centromeric domains. This result is in
agreement with recent findings that silent endogenouserochromatin, transcriptional activity is not strictly cor-
related with nuclear location. At a genomic site in which genes in murine lymphocytes are associated with cen-
tromeres, whereas active genes are found elsewhere instable transgene expression does not require a linked
enhancer, transgenes containing a wild-type or mutant the nucleus (Brown et al., 1997, 1999). In Drosophila,
silencing of the brown gene also involves its localizationenhancer are localized away from centromeres, regard-
less of their transcriptional activity. At genomic sites close to centromeric heterochromatin (Csink and Heni-
koff, 1996; Dernburg et al., 1996). Together, these resultswhere stable expression requires a linked enhancer,
suppression of transgene silencing requires the same suggest that the eukaryotic nucleus is divided into het-
erochromatin compartments that repress transcriptioncore enhancer motifs that are necessary for the classical
enhancer activity of 59HS2. Moreover, disruption of and compartments in which transcription is favored.
They also suggest that positioning of a gene in proximitythese specific cis-acting elements impairs the enhancer-
mediated relocation of the transcriptionally active trans- to the heterochromatic compartment promotes gene
silencing.gene away from centromeric heterochromatin. Thus, an
intact enhancer, and not transcriptional activity per se, The correlation between gene silencing and associa-
tion of a locus with centromeric heterochromatin mayis required for relocation away from centromeric hetero-
chromatin. be comparable to telomeric silencing in yeast. Telomeric
silencing occurs at the nuclear envelope, in compart-
ments in which telomeres are clustered and the concen-Silencing and Proximity to Heterochromatin
When integrated at the unstable expression sites 6.2 tration of SIR proteins is high (Chien et al., 1993; Gotta
and Gasser, 1996; Maillet et al., 1996). Direct evidenceand C30, a transgene linked to a functional enhancer is
in close proximity to a centromeric probe when silent. shows that targeting of a locus to the nuclear periphery
can provoke SIR-mediated silencing (Andrulis et al.,Conversely, when in an active state, it is found at a
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Figure 7. Distance between the Transgene and the Closest Centromere
Distances between the transgene and the nearest centromeric signal were measured for each construct from about 50 interphase nuclei like
those shown in Figure 5. Horizontal bars represent the 10th, 25th, 50th (median), 75th, and 90th percentiles, and p represents the p value for
a pair of samples (see Experimental Procedures). This type of representation indicates that 50% of the population is found between the 25th
and 75th percentiles, and represented as a box. Silent cells are represented by white boxes. Expressing cells are divided into two categories.
Gray boxes denote expressing cells in which the transgene contains either wild-type 59HS2 or 59HS2 with a mutation that does not affect its
ability to retard silencing (mGATA). Expressing cells carrying a transgene with a mutation in 59HS2 that impairs its ability to retard silencing
(mNF-E2 and m4Sites) are shown as gray boxes with hatched bars. The box plots show that silencing is associated with significantly closer
proximity of the transgene and centromeric signals, at sites 6.2 and C30 but not site 1. Disruption of the enhancer, as reflected in loss of its
ability to suppress silencing, is associated with significantly closer proximity of the two signals in active cells when compared with active
cells carrying a functional enhancer. This occurs at sites 6.2 and C30, but not at site 1.
1998). However, in contrast to telomeric silencing, there is progressively silenced, and silencing of the TdT gene
following induced differentiation of immortalized T lym-is no direct evidence that association with centromeric
heterochromatin is the cause of silencing, nor is there phocytes is reversible. The close proximity to centro-
meric heterochromatin of transgenes lacking a func-evidence of a requirement for a gene to localize away
from heterochromatin in order to be transcriptionally tional enhancer may account for the instability of their
expression over time. Conversely, localization of genesactive.
away from centromeres may permit the reversal of their
silent state.Dissociation of Gene Activity
and Subnuclear Location
Our analysis of transgenes integrated in the stable ex- Repositioning of the Transgene away from
Centromeric Heterochromatin Requirespression site 1 demonstrates that a transgene can be
inactive, methylated, in a ªclosedº chromatin conforma- a Functional Enhancer
Our findings, together with the examples discussedtion, but localize away from centromeric heterochroma-
tin in interphase nuclei. The stable expression and activ- above, suggest that a given locus can occupy different
locations in the nucleus: in a centromeric or telomericity-independent positioning of the transgene at site 1
implies that some genomic sites are constitutively disso- compartment nonpermissive for stable gene expres-
sion, or in a compartment in which stable transcriptionalciated from centromeric heterochromatin. This may rep-
resent the default state of such loci in a specific lineage, activity is favored. Our results also present the novel
observation that a functional enhancer can reposition aperhaps due to the presence in the locus of regulatory
elements, such as enhancers or locus control regions sequence away from centromeric heterochromatin.
At site 6.2, the promoterless construct, used as a(LCRs), which maintain the genes in the locus away from
centromeric heterochromatin. trap for targeted reintegration, is in close proximity to
centromeric heterochromatin. Insertion at this site of aWe also found that a transgene can be associated
with centromeric heterochromatin while transcription- construct containing an intact enhancer results in the
relocalization of the same locus away from heterochro-ally active (e.g., mNF-E2 in sites 6.2 and C30). In thymic
lymphoma cell lines, the TdT gene remains away from matin. An enhancer lacking the NF-E2-binding sites, or
all known core binding sites, fails to relocate the activecentromeric sequences regardless of its activity (Brown
et al., 1999). In both of these examples, the activity transgene away from centromeric heterochromatin. Lo-
calization of the transgene away from centromeres atstates are transient and not clonally transmitted: the
transgene in which enhancer activity has been disrupted site C30 also requires an intact NF-E2 site, as does
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stable expression of the transgene. We conclude that failure to target the gene to a transcription factor±rich
the intact enhancer, and not transcription per se, medi- domain.
ates transgene localization away from centromeric het- Perhaps the simplest mechanism for the enhancer-
erochromatin. Moreover, removal of the transgene from mediated relocalization of the transgene would be one
the vicinity of centromeric heterochromatin by an intact in which transcriptional activators disrupt local interac-
enhancer is required for maintenance of the active state. tions between the transgene and heterochromatin, per-
Our results provide evidence that enhancers may pre- mitting it to move into the active compartment. Although
vent a gene from localizing into proximity to hetero- the exact nature of proteins found at the eukaryotic
chromatin and/or ªrecruitº it to an active compartment, centromeres is not known, several proteins involved in
thus preventing it from being silenced. In this respect, PEV, including HP1 (Wreggett et al., 1994), Polycomb
they shed light on studies showing that compartmental- group proteins (Saurin et al., 1998), and Su(var)3-9 (Aa-
ization of genes may be a key event in cell differen- gaard et al., 1999), are associated with constitutive het-
tiation. In the studies of differentiation-mediated gene erochromatin. Given the recent demonstration that Ikaros
silencing in murine lymphocytes, Ikaros, a DNA-binding associates with HDACs, silent genes, and centromeres,
protein, has been shown to be involved in sequestration an attractive possibility is that enhancer-associated fac-
of silenced genes close to pericentromeric regions in B tors (e.g., histone acetyltransferases) disrupt the associ-
lymphocytes (Brown et al., 1997). Similarly, in telomeric ation between genes and heterochromatin proteins,
silencing in yeast, Ku heterodimers, which bind chromo- leading to relocalization of genes away from the centro-
some ends and subtelomeric regions, are involved in meric compartment.
localization of telomeres to the nuclear periphery and Our results reveal another facet of an apparatus that
recruitment of silencing factors (Laroche et al., 1998). is likely to be central to gene expression and cell differ-
The mechanisms by which Ikaros, Ku, and other proteins entiation. If enhancer-mediated transcriptional activa-
promote the sequestration of genetic loci in specific tion results in a gene being positioned in the active
nuclear compartments remain unknown. However, the compartment of the nucleus, and other specific mecha-
recent demonstration that Ikaros also associates with nisms exist to place and keep genes in a silent compart-
histone deacetylases (HDACs) lends support to the ment, then it is likely that these opposed forces interact
model that the nucleoplasm is compartmentalized into to produce the precise programs of stable gene expres-
sites in which specific macromolecules and sequences sion typical of differentiated cells.
concentrate (Kim et al., 1999). Our results suggest that
the action of tissue-specific enhancers may be impor- Experimental Procedures
tant in preventing the inclusion of a linked gene in a
facultative heterochromatin compartment that forms Derivation of Clones and RMCE
Clones were derived by electroporation of K562 cells with a parentduring cell differentiation, thus permitting it to be active
construct, followed by selection with G418 (sites 1 and 6.2) or hygro-in the appropriate lineage.
mycin (site C30). Recombinase-mediated site-specific integration
was obtained using the expression-trap strategy described in Wal-Possible Mechanisms for Enhancer-Mediated
ters et al. (1999) and in Figure 2A. The parent constructs used at
Localization away from sites 6.2 and 1 were, respectively, loxP-59HS2g-loxP b-geo and
Centromeric Heterochromatin loxP-MT-loxP b-geo, in which MT is the metallothionein promoter
We have shown that both stability of expression and (Glanville et al., 1981). At site C30, the parent construct was L1CMV-
HyTkL2. Site-specific recombination using the single LoxP expres-localization of the transgene away from centromeric het-
sion trap method or the RMCE was then as described (Bouhassiraerochromatin correlate with the presence of the HS in
et al., 1997; Walters et al., 1999).the 59HS2 enhancer, suggesting that certain activators,
such as NF-E2 may be responsible for compartmental-
Plasmid Constructs and 59HS2 Mutantsization of the transgene away from centromeric hetero-
The target replacement vectors HS2g-loxP and pL1HS2g/b-geoL2chromatin. However, in our analysis of 59HS2, no single
have been previously described (Walters et al., 1999). 59HS2 consists
motif was sufficient for the enhancer-mediated suppres- of a 1 kb BglII/SmaI fragment from the human b-globin locus and
sion of transgene silencing. Moreover, it is likely that is placed upstream of a 302 bp Ag-globin promoter fragment. Oligo-
proteins binding to the 59HS2 enhancer exert their activ- nucleotide-directed mutagenesis of the 59HS2 core enhancer was
performed by the method of Kunkel et al. (1987) (Phagemid in vitroity through interaction with or recruitment of other pro-
Mutagenesis kit, Bio-Rad). Mutagenic oligonucleotides were usedteins involved in modifying acetylation, methylation,
singly or in combination to generate the mutant sequences shownand/or chromatin structure.
in Figure 1. In (HS2core)g-loxP, a 380 bp HindIII/XbaI fragment con-There are various means by which the intact 59HS2
taining the 59HS2 core enhancer was amplified by PCR with a
enhancer could cause the transgene to move away from 59EcoRI primer and a 39 PstI primer and ligated into the g-loxP
heterochromatin. Through its interaction with transcrip- plasmid (Walters et al., 1999) in which EcoRI and PstI sites had been
tional activators and their partners, 59HS2 could seques- inserted 250 bp 59 of the 59 end of the g-globin promoter. This
construction precisely preserves the spacing between the 59HS2ter the transgene in nuclear compartments containing
core elements and the g-globin promoter found in constructs con-high concentrations of elements of the transcriptional
taining the full-length 59HS2.machinery. In the absence of transcription factor±bind-
ing sites (or in the absence of specific transcription fac-
b-Gal Analysis and Cell Sortingtors in certain cell types), the default localization of a
Fluorescence-activated cell sorter b-galactosidase analysis (FACS-
gene or transgene could be a compartment devoid of, or Gal), with conditions adjusted to maximize sensitivity in detecting
containing low concentrations of, transcription factors, K562 cells expressing b-gal, was performed as described previously
such as the heterochromatin compartment. Alterna- (Walters et al., 1995, 1996). For analysis of silencing, cells were
removed from G418 selection at time point zero and assayed fortively, the lack of such binding sites could result in the
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b-gal activity at intervals of 4 weeks. For each construct at each given by a two-tailed t test for comparison of two unpaired groups.
The experimenter was blinded to the identity of the samples untilintegration site, at least three independently derived clones were
analyzed in two independent experiments, and a SD was generated the point when the box plots were completed.
for each time interval.
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